|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Teufel A, Staib F, Kanzler S, Weinmann A,
Schulze-Bergkamen H and Galle PR: Genetics of hepatocellular
carcinoma. World J Gastroenterol. 13:2271–2282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shah SN and Resar LM: High mobility group
A1 and cancer: Potential biomarker and therapeutic target. Histol
Histopathol. 27:567–579. 2012.PubMed/NCBI
|
|
5
|
Jung KY, Chen K, Kretzler M and Wu C:
TGF-beta1 regulates the PINCH-1-integrin-linked kinase-alph-aparvin
complex in glomerular cells. J Am Soc Nephrol. 18:66–73. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Attwell S, Mills J, Troussard A, Wu C and
Dedhar S: Integration of cell attachment, cytoskeletal
localization, and signaling by integrin-linked kinase (ILK),
CH-ILKBP, and the tumor suppressor PTEN. Mol Biol Cell.
14:4813–4825. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Nie F, Wang S and Li L: Histone H4
Lys 20 monomethylation by histone methylase SET8 mediates Wnt
target gene activation. Proc Natl Acad Sci USA. 108:pp. 3116–3123.
2011; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Curtin JC and Lorenzi MV: Drug discovery
approaches to target Wnt signaling in cancer stem cells.
Oncotarget. 1:552–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang ZG, Yang LY, Wang W, Peng JX, Huang
GW, Tao YM and Ding X: Determination of high mobility group A1
(HMGA1) expression in hepatocellular carcinoma: A potential
prognostic marker. Dig Dis Sci. 50:1764–1770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hannigan GE, Leung-Hagesteijn C,
Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar
S: Regulation of cell adhesion and anchorage-dependent growth by a
new beta 1-integrin-linked protein kinase. Nature. 379:91–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Novak A, Hsu SC, Leung-Hagesteijn C,
Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R and
Dedhar S: Cell adhesion and the integrin-linked kinase regulate the
LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA.
95:pp. 4374–4379. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Attwell S, Roskelley C and Dedhar S: The
integrin-linked kinase (ILK) suppresses anoikis. Oncogene.
19:3811–3815. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Troussard AA, Costello P, Yoganathan TN,
Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase
(ILK) induces an invasive phenotype via AP-1 transcription
factor-dependent upregulation of matrix metalloproteinase 9
(MMP-9). Oncogene. 19:5444–5452. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Delcommenne M, Tan C, Gray V, Rue L,
Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent
regulation of glycogen synthase kinase 3 and protein kinase B/AKT
by the integrin-linked kinase. Proc Natl Acad Sci USA. 95:pp.
11211–11216. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan C, Cruet-Hennequart S, Troussard A,
Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J and
Dedhar S: Regulation of tumor angiogenesis by integrin-linked
kinase (ILK). Cancer Cell. 5:79–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reeves R, Edberg DD and Li Y:
Architectural transcription factor HMGI(Y) promotes tumor
progression and mesenchymal transition of human epithelial cells.
Mol Cell Biol. 21:575–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chan J, Ko FC, Yeung YS, Ng IO and Yam JW:
Integrin-linked kinase overexpression and its oncogenic role in
promoting tumorigenicity of hepatocellular carcinoma. PLoS One.
6:e169842011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peroukides S, Bravou V, Varakis J,
Alexopoulos A, Kalofonos H and Papadaki H: ILK overexpression in
human hepatocellular arcinoma and liver cirrhosis correlates with
activation of Akt. Oncol Rep. 20:1337–1344. 2008.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fusco A and Fedele M: Roles of HMGA
proteins in cancer. Nat Rev Cancer. 7:899–910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fedele M and Fusco A: HMGA and cancer.
Biochim Biophys Acta. 1799:48–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Persad S and Dedhar S: The role of
integrin-linked kinase (ILK) in cancer progression. Cancer
Metastasis Rev. 22:375–384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fuchs BC, Fujii T, Dorfman JD, Goodwin JM,
Zhu AX, Lanuti M and Tanabe KK: Epithelial-to-mesenchymal
transition and integrin-linked kinase mediate sensitivity to
epidermal growth factor receptor inhibition in human hepatoma
cells. Cancer Res. 68:2391–2399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McDonald PC, Oloumi A, Mills J, Dobreva I,
Maidan M, Gray V, Wederell ED, Bally MB, Foster LJ and Dedhar S:
Rictor and integrin-linked kinase interact and regulate Akt
phosphorylation and cancer cell survival. Cancer Res. 68:1618–1624.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng Y, Ritzenthaler JD, Sun X, Roman J
and Han S: Prostaglandin E2 stimulates human lung carcinoma cell
growth through induction of integrin-linked kinase: The involvement
of EP4 and Sp1. Cancer Res. 69:896–904. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang S and Basson MD: Integrin-linked
kinase: A multi-functional regulator modulating extracellular
pressure-stimulated cancer cell adhesion through focal adhesion
kinase and AKT. Cell Oncol. 31:273–289. 2009.PubMed/NCBI
|
|
28
|
Pontier SM, Huck L, White DE, Rayment J,
Sanguin-Gendreau V, Hennessy B, Zuo D, St-Arnaud R, Mills GB,
Dedhar S, et al: Integrin-linked kinase has a critical role in
ErbB2 mammary tumor progression: Implications for human breast
cancer. Oncogene. 29:3374–3385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weaver AM: Invadopodia: Specialized cell
structures for cancer invasion. Clin Exp Metastasis. 23:97–105.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Attwooll C, Denchi E Lazzerini and Helin
K: The E2F family: Specific functions and overlapping interests.
EMBO J. 23:4709–4716. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hulit J, Lee RJ, Russell RG and Pestell
RG: ErbB-2-induced mammary tumor growth: The role of cyclinDl and
p27kipl. Biochem Pharmacol. 64:827–836. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McMahon SB: MYC and the control of
apoptosis. Cold Spring Harb Perspect Med. 4:a0144072014. View Article : Google Scholar : PubMed/NCBI
|
